Ruxolitinib or Dasatinib in Combination with Chemotherapy for Patients with Relapsed/Refractory Philadelphia (Ph)-like Acute Lymphoblastic Leukemia: A Phase I-II Trial
暂无分享，去创建一个
C. Mullighan | M. Konopleva | H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | K. Patel | T. Kadia | F. Ravandi | Koichi Takahashi | E. Jabbour | S. O'brien | N. Jain | J. Jorgensen | W. Wierda | Sa A. Wang | K. Roberts | S. Konoplev | Xinyan Lu | Lina Han | B. Thakral | G. Tang | M. Rytting | Antonio Cavazos | C. Nunez | A. Deshmukh | R. Garris | Patrick Zweider McKay | Rebecca E. Garris